July 25, 2024 by University of Oxford Credit: CC0 Public DomainA study of more than 200,000 people by researchers at the University of Oxford found at least a 17% reduction in dementia diagnoses in the six years after the new recombinant shingles vaccination, equating to 164 or more additional days lived without dementia. The paper...
Two doses of the recombinant zoster vaccine (RZV) are effective against herpes zoster (HZ) for 4 years after vaccination, according to a new study published in the Annals of Internal Medicine. Findings from the prospective cohort study showed that people who received two doses of the vaccine, regardless of when they received their second dose,...
GSK Australia confirmed the availability of its shingles vaccine, Shingrix, as a private script for the prevention of shingles (herpes zoster) and post-herpetic neuralgia (PHN) in people aged 18 years and over who are at increased risk of shingles. Until now, GSK and MSD’s zoster vaccines have only been licensed in Australia for use in...
Shingles is an uncomfortable condition caused by the same virus responsible for chickenpox. The shingles vaccine is a safe and effective tool that can help prevent the condition in eligible adults. The varicella-zoster virus (VZV) is a DNA virus that belongs to the herpesvirus group. After a person recovers from chickenpox, the VZV can remain...
Vaccines are often ineffective in individuals with lymphoma, but a new shingles vaccine may change that, according to a new study. Researchers focused on this hard-to-vaccinate group and how best to prevent this particular illness because people with blood cancers are at higher risk of shingles and its complications, which can be fatal in this population....
Damian McNamara LOS ANGELES — Prevention of shingles with the Zoster Vaccine Live (Zostavax, Merck) may reduce the risk of subsequent stroke among older adults as well, the first study to examine this association suggests. Shingles vaccination was linked to a 20% decrease in stroke risk in people under 80 years of age in the...
LOS ANGELES — Prevention of shingles with the Zoster Vaccine Live (Zostavax, Merck) may reduce the risk of subsequent stroke among older adults as well, the first study to examine this association suggests. Shingles vaccination was linked to a 20% decrease in stroke risk in people under 80 years of age in the large Medicare...
by American Heart Association Shingles, a viral infection caused by the chickenpox virus, is linked to an increased risk of stroke. A new study found that Zoster Vaccine Live, one type of shingles vaccination, may prevent some older adults from having a stroke, according to preliminary research to be presented at the American Stroke Association’s...
The study could offer hope to others with severely compromised immune systems DUKE UNIVERSITY MEDICAL CENTER DURHAM, N.C. – A newer form of shingles vaccine reduced outbreaks of the painful rash among patients who were transplanted with their own stem cells, according to a study led by a Duke Health researcher and published today in...
This image provided by GlaxoSmithKline shows the company’s Shingrix vaccine. The FDA has approved it to prevent painful shingles in people aged 50 or older. On the heels of approval of a better vaccine for the painful condition shingles, adults over 50 should plan to roll up their sleeves — again. The new vaccine, Shingrix, will...
